eISSN: 1994-4624 / ISSN: 1813-176x
Register
Login
International Journal of Molecular Medicine and Advance Sciences
2005, Volume 1, Issue 3 : 268-272 doi: ijmmas.2005.268.272
Research Article
"Is Neoplasia a Sequential Progressiveness in Terms Of Quantitative Variability of Qualitative Cellular Attributes?"
Published
Sept. 30, 2005
Abstract

Fundamental acquisition of the cardinal attributes of a neoplastic lesion might concern the evolving transformation quantitatively of qualitative systems of a sequentially progressive nature. The highly increased proliferative rates of activity of neoplastic tissues would in various ways constitute an integrally sequential series of pathways also actively incorporating the local infiltration of tissues and the complex interplay of involvement constituting metastatic tumor spread in the body. It is indeed in terms of an essential sequential progressiveness that is primarily a biologic attribute of cells that is also potentially an axis of involvement in terms of a neoplastic transformation that one might realize multiple potential pathways of evolution even as an integral carcinogenetic event. It is with regard to a strict definition of carcinogenetic transformation that one might conceptualize a cell proliferative activity as part of an integral sequentiality leading to activated progressiveness of cell biologic attributes. Such sequential progressiveness of cell biology would perhaps be strictly characterized as a true form of pathobiologic transformation of neoplastic type simply in terms of induced quantitative variability influencing paradoxically qualitative determinants of cellular activity. In such terms, malignant cellular transformation would specifically arise as an integral system of pathologic evolution inherent to distinct biologic progressiveness of various cellular attributes referable to metabolic, proliferative, membrane physiologic, oxidative and genetic type as quantitatively variable but sequentially progressive even as transformational events.

Keywords
License
Copyright (c) International Journal of Molecular Medicine and Advance Sciences
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
Int. J. Mol. Med. Adv. Sci. open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Recommended Articles
“Outcomes of TAVR vs SAVR Among High-Risk Patients”
39-42
Impact of Dual Antiplatelet Therapy Duration on Post-PCI Outcomes
11-14
Percutaneous Balloon Angioplasty as First-Line Therapy in Low-Income Patients
31-34
Professionalism and Ethics Education in Medical Schools: Assessing Knowledge, Attitudes, and Educational Outcomes Among Medical Students
16-20
International Journal of Molecular Medicine and Advance Sciences
+447480266638
+447480266638
support@ijmmas.com
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives (CC BY-NC-ND) license. Open Access Publication.
Copyright © ©International Journal of Molecular Medicine and Advance Sciences. All rights reserved.